South Korea Gearing Up To Fight Tuberculosis
This article was originally published in PharmAsia News
Executive Summary
To eliminate perceptions that South Korea stands out among OECD countries as a safe haven for TB, the government is rolling out specific tools to combat the deadly lung disease.
You may also be interested in...
South Korea's Green Cross Begins "Test Production" of Flu Vaccine
SEOUL - South Korean pharmaceutical company Green Cross recently started "test production" of its own A/H1N1 flu vaccine, after receiving a virus strain from the UK's National Institution for Biological Standards and Control and from the Centers for Disease Control and Prevention of the U.S
U.S. And Korea Step Up Fight Against Tuberculosis, Launch TB Research Center
SEOUL - In a bid to wipe out perceptions that South Korea remains a "safe heaven" for tuberculosis, the country is strengthening cooperation with the U.S. in a joint attack on the potentially fatal disease
Early-Stage Idiopathic Pulmonary Fibrosis (IPF) Candidates Race to Phase III
Multiple IPF drugs are being rushed into Phase III based on early-stage signals of efficacy and safety presented at the ATS meeting. Scrip spoke with the University of Pittsburgh's Kevin Gibson about the candidates, trial design, combination therapy and limitations of current therapy.